Other news

u-card-img-1
News

Rapport annuel 2021

Découvrez nos chercheurs, leurs avancées scientifiques et comment certaines découvertes ont été traduites en applications pour la santé humaine.

Learn more
u-card-img-1
News
Publication in Science Translational Medicine

Genetic cause identified for a severe form of lymphedema

The team of Miikka Vikkula (WELBIO - UCLouvain) and colleagues have discovered a genetic cause for CCLA, a serious and rare disease affecting the central lymphatic vessel system.

Learn more
u-card-img-1
News
Publication in Science

An innovative approach to treating brain diseases

Benoît Vanholleke (WELBIO-ULB) and his team found how modulating Gpr124/ restores the permeability of cerebral blood vessels in models of brain pathologies.  

Learn more
u-card-img-1
News
Publication in PNAS

A link between sugar metabolism and Parkinson’s disease

Guido Bommer (WELBIO-UCLouvain) and his team identify a new role for PARK7  an enzyme that is inactive in some Parkinson's disease patients.

Learn more
u-card-img-1
News
Publication in NANOLetters

Nanobiophysical approach offers new perspectives for oncolytic cancer therapy

David Alsteens (WELBIO - UCLouvain) and his team demonstrate the role of α-sialylated glycans in enhancing oncolytic therapy in breast cancer using atomic force microscopy.

Learn more
u-card-img-1
News
European Association for Cancer Research (EACR) Prize

EACR’s Mike Gold Medal Award 2022 to Cédric Blanpain

Cédric Blanpain (WELBIO - ULB) is the 2022 winner of the EACR’s Mike Price Gold Medal, which rewards a senior researcher who has made an outstanding contribution to the progress of cancer research in Europe.

Learn more
u-card-img-1
News
Publication in Oncogene

A dual role for COP1 in breast cancer

Alain Chariot (WELBIO – ULiège) and his team demonstrated that COP1 can act as an oncogenic E3 ligase by promoting ERa signaling but also as a tumor suppressor candidate by preventing epithelial-mesenchymal transition.

Learn more
u-card-img-1
News
Spin-off creation

Santero Therapeutics: Towards a new generation of antibiotics

From fundamental research on bacterial metabolism in Abel Garcia-Pino's laboratory (WELBIO - ULB) to the development of a new generation of antibiotics.

Learn more
u-card-img-1
News
Queen Elisabeth Medical Foundation Prize 2020

Ernest Solvay Prize to Benoît Vanhollebeke

The Ernest Solvay 2020 Prize of the Queen Elisabeth Medical Foundation was awarded to Benoît Vanhollebeke (WELBIO - ULB) at a ceremony attended by Her Majesty the Queen.

Learn more
u-card-img-1
News

Launch of the 2021 WELBIO Investigator Programme call!

The FRFS-WELBIO announces its 2021 call for "WELBIO Investigator programmes" for basic research in the fields of life sciences that can lead to applications in all fields of (bio)technology.

Learn more
u-card-img-1
News
Prix Quinquennaux FNRS 2020

Prix scientifique Joseph Maisin à Jean-François Collet

Le Prix Joseph Maisin en Sciences biomédicales fondamentales 2020 a été attribué à Jean-François Collet (WELBIO - UCLouvain) lors d’une cérémonie en présence de Sa Majesté le Roi.

Learn more
u-card-img-1
News
Publication in Molecular Cell

A magic alarmone to rescue hungry bacteria

Abel Garcia-Pino (WELBIO – ULB) and his team shed light on the role played by  alarmone for induction of the synthetic activity of E. coli RelA by starved ribosomes.

Learn more

Share this page